Left ventricular pacing site optimisation in cardiac resynchronisation therapy

Cardiac resynchronisation therapy (CRT) can improve symptoms, ventricular function and survival in carefully selected patients with heart failure and electrical dyssynchrony. Yet the procedure is not defined by device implantation alone. The position, stability and electrical performance of the left ventricular (LV) lead can determine whether resynchronisation produces a meaningful clinical response.

The coronary venous system offers several possible pacing locations, but these sites are not interchangeable. A lateral or posterolateral branch may provide excellent activation in one patient and poor capture, phrenic nerve stimulation or limited haemodynamic benefit in another. Scar, venous anatomy, lead stability and the relationship between electrical delay and mechanical contraction all influence the result.

For Australian electrophysiology teams, optimisation also needs to reflect local practice. Patients may be referred from regional Queensland, Western Australia or the Northern Territory to metropolitan implant centres, while public and private pathways can involve different waiting times and follow-up arrangements. A reproducible strategy helps make each procedure count, particularly when repeat intervention is difficult for people who live far from tertiary cardiac services.

Why the left ventricular lead position matters

Conventional biventricular CRT coordinates right ventricular and LV activation through a pacing lead placed in a coronary sinus tributary. The objective is to stimulate a region that is activated late, allowing the pacing wavefront to recruit viable myocardium and reduce interventricular and intraventricular dyssynchrony. In patients with left bundle branch block, the target is commonly a lateral or posterolateral region rather than the anterior or apical wall.

The ideal site is therefore patient-specific. A lead positioned in a region of dense myocardial fibrosis may achieve an acceptable pacing threshold while producing little functional improvement. In ischaemic cardiomyopathy, the posterolateral wall can contain scar from a circumflex territory infarct, making an alternative vein preferable. Cardiac magnetic resonance imaging with late gadolinium enhancement can help identify scar, although access and device compatibility may affect its use.

Lead position also has practical consequences. A stable branch with a suitable diameter, low capture threshold and adequate distance from the phrenic nerve is usually more valuable than an anatomically attractive location that cannot be programmed reliably. Venography, quadripolar lead technology and careful testing of multiple vectors have expanded the available options, but they do not remove the need for individual assessment.

Mapping electrical and mechanical delay

Electrical delay is often assessed by measuring the interval from the onset of the surface QRS complex to local ventricular electrogram activation at candidate coronary venous sites. A late-activated region may be a useful target, particularly when the lead can be placed in viable myocardium. However, the longest delay is not automatically the best pacing location, and measurements can vary with catheter stability, lead orientation and rhythm.

Echocardiography can add information about mechanical dyssynchrony, regional strain and myocardial viability. Speckle-tracking analysis may identify the latest contracting segment, while three-dimensional imaging can clarify ventricular volumes and remodelling. These methods are valuable for selected cases, although routine echo-based site selection has not consistently produced superior outcomes across broad CRT populations.

A more pragmatic approach combines pre-procedural imaging, intraoperative electrical measurements and post-implant response. QRS narrowing, haemodynamic changes, capture thresholds and the absence of phrenic stimulation should be considered together. In some centres, acute haemodynamic assessment or non-invasive blood pressure surrogates are used during lead testing, but resource-intensive techniques need to demonstrate a clear benefit before widespread adoption.

The choice of pacing site should also account for the underlying conduction pattern. In non-ischaemic cardiomyopathy with typical left bundle branch block, a lateral target may work well. In patients with atypical conduction disease, right bundle branch block, prior surgery or extensive scar, the relationship between surface ECG morphology and the best LV target can be less predictable.

Procedural strategies for difficult venous anatomy

Coronary sinus venography remains central to LV lead implantation. Operators assess ostial access, venous calibre, tortuosity, branch angle and the presence of collateral channels before selecting a target. A posterolateral branch is frequently preferred, but an anterolateral or mid-lateral branch may be a better compromise when the usual target is inaccessible or associated with high pacing thresholds.

Quadripolar leads allow different electrode combinations to be tested after deployment. This can reduce the impact of lead position that is slightly less than ideal and may provide a vector that avoids phrenic nerve stimulation. Active fixation systems and advanced delivery sheaths can improve stability in challenging anatomy, although they add procedural complexity and require familiarity with device-specific handling.

When conventional transvenous CRT is unsuccessful, alternatives include surgical epicardial LV leads, endocardial approaches in highly selected settings and conduction system pacing. His-bundle pacing and left bundle branch area pacing can recruit the native conduction system and may be considered when coronary venous anatomy is unsuitable, CRT response is inadequate or venous lead complications occur. These techniques have distinct learning curves and long-term evidence bases, so the choice should be made by an experienced multidisciplinary team.

This issue is especially relevant in Australia, where a patient from regional New South Wales or far north Queensland may need substantial travel for a lead revision. Planning the first procedure carefully, including early review of imaging and venous access, can reduce repeat admissions. In a public hospital, theatre availability and device procurement may also influence scheduling, while private patients may have more immediate access but still require coordinated cardiology, imaging and device-clinic follow-up.

Programming and assessing response

Successful LV lead placement is followed by programming that preserves effective biventricular capture. Atrioventricular and interventricular timing can be adjusted using surface ECG, echocardiographic measures, invasive haemodynamics or device algorithms. Routine optimisation for every patient has not consistently outperformed a well-programmed default, but targeted assessment is sensible when symptoms, QRS duration or ventricular function fail to improve.

The clinical response should be assessed over time rather than judged from a single early measurement. Relevant outcomes include NYHA functional class, exercise capacity, congestion, heart failure admissions, LV ejection fraction, end-systolic volume and quality of life. Device interrogation should document biventricular pacing percentage, atrial arrhythmia burden, lead impedance, capture thresholds and any episodes of phrenic nerve stimulation.

A high reported pacing percentage does not always mean effective resynchronisation. Frequent premature ventricular complexes, intermittent loss of capture, atrial tachyarrhythmias and fusion or pseudofusion can reduce the physiological benefit. Programming changes, rhythm control, atrioventricular node ablation or ventricular ectopy treatment may be needed to maintain consistent therapy.

Long-term surveillance also protects against complications that can obscure CRT benefit. Lead dislodgement, venous obstruction, infection and battery depletion require device-clinic review. Patients with a history of atrial fibrillation or prior ablation may develop symptoms that are wrongly attributed to CRT failure; a pericarditis management report illustrates why competing diagnoses should remain in the assessment.

Managing non-response and future directions

Around one-third of patients may show limited symptomatic or reverse-remodelling benefit after CRT, depending on the definition and population studied. Non-response should prompt a structured review rather than an immediate assumption that the pacing site is wrong. Clinicians should reassess the original indication, medication adherence, ischaemia, valve disease, scar burden, atrial fibrillation, ventricular ectopy and the actual percentage of effective biventricular pacing.

Lead repositioning may be appropriate when the existing site lies within scar, produces persistent phrenic stimulation or has poor electrical performance. Before revision, imaging and venography can clarify whether another coronary vein is available. In some patients, a multipoint pacing strategy or a new quadripolar vector may improve activation without moving the lead, although benefits are variable and should be confirmed clinically.

The distinction between CRT non-response and pacing-induced deterioration is important. Right ventricular pacing burden, ventricular dyssynchrony and progressive LV dysfunction may contribute to cardiomyopathy in patients who were initially paced for bradycardia or atrioventricular block. A detailed pacing cardiomyopathy review can support diagnostic reasoning when the clinical picture is evolving.

Future approaches are likely to combine electroanatomical mapping, scar imaging, automated lead-location analysis and personalised multipolar programming. Conduction system pacing may broaden the options for patients who cannot receive conventional CRT, while leadless and wireless technologies remain areas of active investigation. Australian centres participating in multicentre studies can contribute valuable data from geographically diverse populations, including patients who face long-distance access barriers and differences between state-based health systems.

Clinicians, researchers and trainees can share relevant studies, technical reports and clinical observations with the Journal of Arrhythmia community. For manuscript queries, peer-review matters or publication information, contact the editorial office and help advance evidence-based approaches to ventricular resynchronisation.